McGill University Health Centre-CIM - Oncology ( Site 0306)

Montreal, Quebec H4A 3J1

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer

Studies at this site

• Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008). — Running, not enrolling